Skip to main navigation Skip to search Skip to main content

Effectiveness and safety of the bevacizumab and erlotinib combination versus erlotinib alone in EGFR mutant metastatic non-small-cell lung cancer: systematic review and meta-analysis

  • Rodrigo Motta-Guerrero
  • , Alejandro Leon Garrido-Lecca
  • , Virgilio E. Failoc-Rojas
  • , Ana Calle-Villavicencio
  • , Robert Villacorta-Carranza
  • , Yesenia Huerta-Collado
  • , Alicia Torres-Mera
  • , Mario J. Valladares-Garrido
  • , Víctor Rivera-Francia
  • , Carlos Carracedo
  • , Luis Raez

Research output: Contribution to journal › Review article › peer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Effectiveness and safety of the bevacizumab and erlotinib combination versus erlotinib alone in EGFR mutant metastatic non-small-cell lung cancer: systematic review and meta-analysis'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology